Finance

Lists
ELIC:STO
Elicera Therapeutics AB
SEK 2.66
-1.84%
(-0.050) 1D
Sep 28, 5:29:33 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ELIC...
Open
SEK 2.72
High
SEK 2.74
Low
SEK 2.66
Mkt. cap
177.53M
Avg. vol.
321.11K
Volume
362.11K
52-wk high
SEK 8.21
52-wk low
SEK 2.24
EPS
-SEK 0.35
Shares outstanding
66.74M
No. of employees
3
Open
SEK 2.72
High
SEK 2.74
Low
SEK 2.66
Mkt. cap
177.53M
Avg. vol.
321.11K
Volume
362.11K
52-wk high
SEK 8.21
52-wk low
SEK 2.24
EPS
-SEK 0.35
Shares outstanding
66.74M
No. of employees
3
About Elicera Therapeutics AB
CEO-
Employees3
Founded2014
Headquarters-
SectorBiotechnology
Websiteelicera.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.91M
30.00K
-
-147.66K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.76M
7.16M
5.12M
6.16M
Operating expense
7.76M
7.16M
5.12M
6.16M
Total operating expenses
7.76M
7.16M
5.12M
6.16M
Operating income
146.69K
-7.13M
-5.12M
-6.31M
Other non operating income
1.32K
-
-
-4.00K
EBT including unusual items
304.15K
-6.97M
-5.06M
-6.26M
EBT excluding unusual items
304.15K
-6.97M
-5.06M
-6.26M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
304.15K
-6.97M
-5.06M
-6.26M
Net profit margin
3.85%
-23,219.94%
-
4,240.78%
Earnings per share
-
-
-
-
Interest and investment income
156.14K
169.41K
61.50K
47.75K
Interest expense
-
-5.07K
-4.78K
-45.00
Net interest expenses
156.14K
164.34K
56.72K
47.71K
Depreciation and amortization charges
-
-
-
-
EBITDA
149.63K
-7.13M
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps